The ISG15 axis: a central mediator and therapeutic target in vascular inflammaging
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 07.05.2026 · 81 (6)
DOI: 10.1093/gerona/glag087 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 07.04.2026. Verfasst von Ziwei Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Aging, Inflammation, Cardiovascular System, Cytokines. Die Arbeit nennt 87 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Vascular aging, which is characterized by the progressive decline in the structure and function of blood vessels, is a primary driver of cardiovascular morbidity and mortality in older adults. Although chronic low-grade inflammation (inflammaging) and cellular senescence are central to this process, the molecular nodes that integrate these pathways are not well understood. This review proposes that interferon-stimulated gene 15 (ISG15), a well-established ubiquitin-like modifier in antiviral defense, acts as a critical nexus linking these pathological hallmarks in vascular aging. ISG15 is proposed to function through a dual mechanism: extracellularly, it propagates pro-inflammatory signaling; intracellularly, its covalent conjugation to target proteins (ISGylation) disrupts core homeostatic processes. The review presents evidence demonstrating that the ISG15 system, when activated by sterile triggers via the cGAS-STING pathway, drives endothelial dysfunction and vascular smooth muscle cell phenotypic switching by exacerbating oxidative stress, inducing cellular senescence, and disrupting proteostasis. Consequently, the ISG15 axis is established as a compelling therapeutic target. The rationale behind strategies that range from the direct inhibition of ISGylation and the neutralization of extracellular ISG15, to the repurposing of existing upstream interferon-pathway inhibitors, is discussed. Key outstanding questions are outlined to guide future research, paving the way for novel diagnostics and interventions aimed at preserving vascular health during aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Key Laboratory of Vascular Aging, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Le Zhang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Shenzhen Medical Research Fund
Zitieren
APA
Fang, Z., Nie, S., Chen, H., Deng, C., Zhang, C., & Zhang, L. (2026). The ISG15 axis: a central mediator and therapeutic target in vascular inflammaging. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(6). https://doi.org/10.1093/gerona/glag087
Vancouver
Fang Z, Nie S, Chen H, Deng C, Zhang C, Zhang L. The ISG15 axis: a central mediator and therapeutic target in vascular inflammaging. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(6). doi:10.1093/gerona/glag087
BibTeX
@article{Fang2026,
author = {Fang, Ziwei and Nie, Shuyi and Chen, Hualin and Deng, Chenxin and Zhang, Cuntai and Zhang, Le},
title = {The ISG15 axis: a central mediator and therapeutic target in vascular inflammaging},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2026},
volume = {81},
number = {6},
doi = {10.1093/gerona/glag087}
}
EUVIMED